Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Greta Volpedo, Ryan H Huston, Erin A Holcomb, Thalia Pacheco-Fernandez, Sreenivas Gannavaram, Parna Bhattacharya, Hira L Nakhasi & Abhay R Satoskar. (2021) From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection. Expert Review of Vaccines 20:11, pages 1431-1446.
Read now
Read now
Alireza Firooz, Hossein Mortazavi, Ali Khamesipour, Maryam Ghiasi, Robabeh Abedini, Kamran Balighi, Nafiseh Esmaili, Mansour Nassiri-Kashani, S. Ebrahim Eskandari, Mehdi Mohebali, Akram Mir Amin Mohammadi & Yahya Dowlati. (2021) Old world cutaneous leishmaniasis in Iran: clinical variants and treatments. Journal of Dermatological Treatment 32:7, pages 673-683.
Read now
Read now
Articles from other publishers (8)
Prakash Kumar, Pawan Kumar, Nidhi Singh, Salil Khajuria, Rahul Patel, Vinod Kumar Rajana, Debabrata Mandal & Ravichandiran Velayutham. (2022) Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Patrícia Severino, Wanessa Santana, Erika S. Lisboa, Victoria L. S. dos Santos, Erica T. dos Santos Lima, Juliana C. Cardoso, Ricardo L. C. de Albuquerque-Junior, Beatriz C. Naveros, Antonello Santini, Eliana B. Souto & Sona Jain. (2022) Cutaneous/Mucocutaneous Leishmaniasis Treatment for Wound Healing: Classical versus New Treatment Approaches. Microbiology Research 13:4, pages 836-852.
Crossref
Crossref
Tammy Haro-Reyes, Lucero Díaz-Peralta, Arturo Galván-Hernández, Anahi Rodríguez-López, Lourdes Rodríguez-Fragoso & Iván Ortega-Blake. (2022) Polyene Antibiotics Physical Chemistry and Their Effect on Lipid Membranes; Impacting Biological Processes and Medical Applications. Membranes 12:7, pages 681.
Crossref
Crossref
Nasma I. Al-Mamary & Haitham L. Al-Hayali. (2022) Effect of Synergism of Thalidomide and Liposomal Amphotericin-B on Leishmania tropica and Leishmania donovani Promastigote. Bionatura 7:2, pages 1-9.
Crossref
Crossref
Gert-Jan Wijnant, Franck Dumetz, Laura Dirkx, Dimitri Bulté, Bart Cuypers, Katrien Van Bocxlaer & Sarah Hendrickx. (2022) Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Gabrielle dos Santos da Silva e Miranda, Joseane Lima Prado Godinho, Sara Teixeira de Macedo-Silva, Brunno Renato Farias Verçoza, Alisson Amaral da Rocha, Milena Barenco Pires de Abreu Sodré, Victor Feliciano dos Santos Ramos & Juliany Cola Fernandes Rodrigues. 2022. Leishmaniasis - General Aspects of a Stigmatized Disease. Leishmaniasis - General Aspects of a Stigmatized Disease.
Maria Ubals, Pau Bosch-Nicolau, Adrián Sánchez-Montalvá, Fernando Salvador, Gloria Aparicio-Español, Elena Sulleiro, Aroa Silgado, Antoni Soriano-Arandes, Maria Espiau, Berta Ferrer, Diana Pou, Begoña Treviño, Israel Molina & Vicente García-Patos. (2021) Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B. Pathogens 10:10, pages 1253.
Crossref
Crossref
Sarah Forrester, Karin Siefert, Helen Ashwin, Najmeeyah Brown, Andrea Zelmar, Sally James, Dimitris Lagos, Jon Timmis, Mitali Chatterjee, Jeremy C. Mottram, Simon L. Croft & Paul M. Kaye. (2019) Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis. Wellcome Open Research 4, pages 198.
Crossref
Crossref